Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace

FISH probes, 9/16

September 2016—Oxford Gene Technology has expanded its catalog of fluorescence in situ hybridization products with nine Cytocell Aquarius probes: ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua, and Chromosome 15 Alpha Satellite Probe Red.

Genomic Health, Epic Sciences collaboration, 9/16

September 2016—Genomic Health and Epic Sciences announced an exclusive agreement to commercialize Epic Sciences’ novel AR-V7 liquid biopsy test in the U.S. through Genomic Health’s commercial channel. The blood-based test detects the V7 variant of the androgen receptor protein in the nucleus of circulating tumor cells—information that can help guide treatment selection in patients with metastatic castration-resistant prostate cancer.

CE mark for shiga toxin test, 9/16

September 2016—Great Basin Scientific announced that its Shiga Toxin Direct Test received CE marking under the European directive on in vitro diagnostic medical devices. The test is now qualified for distribution in more than 32 countries across Europe.

Live cell imaging system, 9/16

September 2016—The CellAsic Onix2 Microfluidic System for live cell imaging aims to give researchers precise environmental control over live cells. The small control system fits next to the microscope and the low-profile manifold and plate sit on top of the microscope stage, delivering precise control of gas, temperature, media changes, and more.

Urine collection tube, 9/16

September 2016—Sarstedt introduced its 3.2 mL Urine Monovette tube in a 13 mm × 75 mm configuration for smaller volume or dimensional requirements. The Urine Monovette system enables hygienic urine collection and testing without needles, adapters or cups, or transfers.

Liquid biopsy workflow for NGS system, 9/16

September 2016—Qiagen launched a liquid biopsy workflow for clinical cancer research using its GeneReader NGS System for next-generation sequencing. The Actionable Insights Tumor Panel is a sample-to-insight solution for noninvasive liquid biopsies and formalin-fixed, paraffin-embedded tissue samples.

Liquid pepsin, 9/16

September 2016—SciGene introduced its CytoZyme HC Stabilized Pepsin, a high-potency solution used for digesting any tissue for FISH assays. Purified liquid CytoZyme HC provides consistent activity for more than 12 months at 4°C.

Medical-grade countertop refrigerator, 9/16

September 2016—Helmer Scientific released its MLR102 medical-grade countertop refrigerator with AdvanceCore cooling technology. The refrigerator is used to safeguard expensive, life-saving vaccines and medications as well as sensitive, and at times irreplaceable, reagents and patient samples.

CE mark for herpes virus test, 9/16

September 2016—SpeeDx received CE-IVD marking for its PlexPCR HSV-1&2, VZV multiplex qPCR kit. The multiplex molecular diagnostic test offers a single-well solution to cover the detection and differentiation of three herpes viruses (HSV-1, HSV-2, VZV) in addition to an internal control.